| /s/ Chaim Lebovits Chaim Lebovits Chief Executive Officer | | | | |
| BY ORDER OF THE BOARD OF DIRECTORS | | | ||
| /s/ Uri Yablonka Uri Yablonka, Chief Business Officer and Secretary New York, New York November 8, 2023 | | | | |
| Routine | | | Non-Routine | |
| Proposal No. 2 — Ratification of Deloitte as the Company’s independent registered public accounting firm. | | | Proposal No. 1 — Election of Directors. | |
| | | Shares Beneficially Owned (Includes Common Stock, Presently Exercisable Options and Presently Exercisable Warrants) | | |||||||||
Name of Beneficial Owner | | | # | | | % | | ||||||
Directors and Named Executive Officers | | | | | | | | | | | | | |
Chaim Lebovits | | | | | 2,663,761(1) | | | | | | 5.45% | | |
Stacy Lindborg | | | | | 281,500(2) | | | | | | * | | |
Alla Patlis | | | | | 13,600(3) | | | | | | * | | |
Ralph Kern | | | | | — | | | | | | * | | |
Uri Yablonka | | | | | 157,540(4) | | | | | | * | | |
June Almenoff | | | | | 13,175(5) | | | | | | * | | |
Irit Arbel | | | | | 383,831(6) | | | | | | * | | |
Anthony Polverino | | | | | 25,960(7) | | | | | | * | | |
Nir Naor | | | | | — | | | | | | * | | |
Jacob Frenkel | | | | | 206,667(8) | | | | | | * | | |
Menghisteab Bairu | | | | | — | | | | | | * | | |
All current directors and executive officers as a group (11 persons) | | | | | 2,972,036 | | | | | | 5.45% | | |
5% Shareholders (other than listed above) | | | | | | | | | | | | | |
Kevin D. Ness | | | | | 3,660,000(9) | | | | | | 7.55% | | |
Sankesh Abbhi | | | | | 2,175,853(10) | | | | | | 4.49% | | |
Name | | | Age | | | Position | |
Dr. Jacob Frenkel | | | 80 | | | Chairperson and Director | |
Dr. Irit Arbel | | | 63 | | | Vice-Chairperson and Director | |
Dr. Menghisteab Bairu | | | 63 | | | Director | |
Nir Naor | | | 49 | | | Director | |
Dr. Anthony Polverino | | | 61 | | | Director | |
Uri Yablonka | | | 47 | | | Director, EVP, Chief Business Officer and Secretary | |
Board Diversity Matrix (As of November 8, 2023) | | | | | |||||||||||||||||||||||||||
Total Number of Directors | | | 7 | | | | | | | | | | | ||||||||||||||||||
| | | Female | | | Male | | | Non-Binary | | | Did Not Disclose Gender | | | | | |||||||||||||||
Part I: Gender Identity | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||
Directors | | | | | 1 | | | | | | 3 | | | | | | | | | 3 | | | | | | ||||||
Part II: Demographic Background | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||
African American or Black | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||
Alaskan Native or Native American | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||
Asian | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||
Hispanic or Latinx | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||
Native Hawaiian or Pacific Islander | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||
White | | | | | 1 | | | | | | 3 | | | | | | | | | | | | | | | ||||||
Two or More Races or Ethnicities | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||
LGBTQ+ | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||
Did Not Disclose Demographic Background | | | | | | | | | | | | | | | | | | | | 3 | | | | | | ||||||
Part III: Supplemental Self-Identification | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||
Military Veteran | | | | | 1 | | | | | | | | | | | | | | | | | | | | | ||||||
Middle Eastern | | | | | 1 | | | | | | | | | | | | | | | | | | | | |
Name | | | Age | | | Position | |
Chaim Lebovits | | | 52 | | | Chief Executive Officer | |
Stacy Lindborg, Ph.D. | | | 53 | | | Co-Chief Executive Officer | |
Alla Patlis | | | 37 | | | Interim Chief Financial Officer and Controller | |
Uri Yablonka | | | 47 | | | Executive Vice President, Chief Business Officer, Secretary and Director | |
Name and Principal Position | | | Year | | | Salary ($) | | | Bonus ($) | | | Stock Awards ($)(1) | | | All Other Compensation ($)(2) | | | Total ($) | | ||||||||||||||||||
Chaim Lebovits (*), President & Chief Executive Officer | | | | | 2022 | | | | | | 500,000 | | | | | | 250,000(3) | | | | | | 127,547 | | | | | | 240,419 | | | | | | 1,117,966 | | |
| | | | | 2021 | | | | | | 500,000 | | | | | | 250,000(4) | | | | | | 110,395 | | | | | | 267,954 | | | | | | 1,128,349 | | |
Ralph Kern, Former President & Former Chief Medical Officer | | | | | 2022 | | | | | | 500,000 | | | | | | 150,000(5) | | | | | | 106,220 | | | | | | 56,339 | | | | | | 812,559 | | |
| | | | | 2021 | | | | | | 500,000 | | | | | | 250,000(6) | | | | | | 125,971 | | | | | | 62,862 | | | | | | 938,833 | | |
Stacy Lindborg, Co-Chief Executive Officer(7) | | | | | 2022 | | | | | | 469,000 | | | | | | 164,150(8) | | | | | | 143,150 | | | | | | 75,243 | | | | | | 851,543 | | |
| | | | | 2021 | | | | | | 469,000 | | | | | | 189,150(9) | | | | | | — | | | | | | 78,530 | | | | | | 736,680 | | |
| | | Option Awards | | | Stock Awards | | ||||||||||||||||||||||||||||||
Name | | | Number of Securities Underlying Unexercised Options (#) Exercisable | | | Number of Securities Underlying Unexercised Options (#) Unexercisable | | | Option Exercise Price ($) | | | Option Expiration Date | | | Number of Shares or Units of Stock That Have Not Vested (#) | | | Market Value of Shares or Units of Stock That Have Not Vested ($)(1) | | ||||||||||||||||||
Chaim Lebovits | | | | | 369,619 | | | | | | — | | | | | | 2.45 | | | | | | 9/28/2025 | | | | | | — | | | | | | — | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | 7,796(2) | | | | | | 12,785 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | 15,593(3) | | | | | | 25,573 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | 23,389(4) | | | | | | 38,358 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | 31,185(5) | | | | | | 51,143 | | |
Ralph Kern | | | | | 40,000 | | | | | | 40,000(10) | | | | | | 7.33 | | | | | | 03/09/2030 | | | | | | — | | | | | | — | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | 8,971(6) | | | | | | 14,712 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | 17,943(7) | | | | | | 29,427 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | 26,914(8) | | | | | | 44,139 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | 35,885(9) | | | | | | 58,851 | | |
Stacy Lindborg | | | | | 93,750 | | | | | | 6,250(11) | | | | | | 7.67 | | | | | | 01/06/2030 | | | | | | 35,000(12) | | | | | | 57,400 | | |
Year | | | Summary Compensation Table Total for PEO($)(1)(2) | | | Compensation Actually Paid To PEO($)(1)(3) | | | Average Summary Compensation Table Total for Non-PEO NEOs($)(1)(2) | | | Average Compensation Actually Paid to Non-PEO NEOs($)(1)(3) | | | Value of initial fixed $100 investment based on total shareholder return (TSR)($)(4): | | | Net Loss($)(5) (in thousands) | | ||||||||||||||||||
2022 | | | | | 1,117,966 | | | | | | 897,254 | | | | | | 832,051 | | | | | | 631,570 | | | | | | 36 | | | | | $ | (24,277) | | |
2021 | | | | | 1,128,349 | | | | | | 1,089,130 | | | | | | 837,757 | | | | | | 780,137 | | | | | | 88 | | | | | $ | (24,457) | | |
2022 | | | PEO | | | Non-PEO NEOs | | ||||||
SCT Total Compensation | | | | $ | 1,117,966 | | | | | $ | 832,051 | | |
Deduct amounts reported under the “Stock Awards” and “Option Awards” column of the SCT | | | | $ | (127,547) | | | | | $ | (124,685) | | |
Add Fair Value of Awards Granted in 2022 Unvested as of 12/31/22 | | | | $ | 51,143 | | | | | $ | 58,126 | | |
Add (Deduct) Change in Fair Value of Awards Granted in Prior Years Unvested as of 12/31/22 | | | | $ | (110,395) | | | | | $ | (100,580) | | |
Add (Deduct) Change in Fair Value of Awards Granted in Prior Years that Vested during 2022 as of the Vesting Date | | | | $ | (33,914) | | | | | $ | (33,342) | | |
Total Compensation Actually Paid | | | | $ | 897,253 | | | | | $ | 631,570 | | |
2021 | | | PEO | | | Non-PEO NEOs | | ||||||
SCT Total Compensation | | | | $ | 1,128,349 | | | | | $ | 837,757 | | |
Deduct amounts reported under the “Stock Awards” and “Option Awards” column of the SCT | | | | $ | (110,395) | | | | | $ | (62,986) | | |
Add Fair Value of Awards Granted in 2021 Unvested as of 12/31/21 | | | | $ | 124,736 | | | | | $ | 71,170 | | |
Add (Deduct) Change in Fair Value of Awards Granted in Prior Years Unvested as of 12/31/21 | | | | $ | (24,792) | | | | | $ | (29,438) | | |
Add (Deduct) Change in Fair Value of Awards Granted in Prior Years that Vested during 2021 as of the Vesting Date | | | | $ | (28,768) | | | | | $ | (36,366) | | |
Total Compensation Actually Paid | | | | $ | 1,089,130 | | | | | $ | 780,137 | | |
Name | | | Fees Earned or Paid in Cash ($) | | | Stock Awards ($)(1) | | | Option Awards ($)(1) | | | Total ($) | | ||||||||||||
Dr. Jacob Frenkel | | | | | — | | | | | | — | | | | | | 152,811(2) | | | | | | 152,811 | | |
Dr. Irit Arbel | | | | | — | | | | | | — | | | | | | —(3) | | | | | | — | | |
Dr. June S. Almenoff(4) | | | | | 30,000 | | | | | | — | | | | | | — | | | | | | 30,000 | | |
Dr. Anthony Polverino | | | | | 12,500 | | | | | | 12,112(5) | | | | | | — | | | | | | 24,612 | | |
Dr. Menghisteab Bairu(6) | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Mr. Malcolm Taub(7) | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Mr. Uri Yablonka(8) | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | | December 31, | | |||||||||
| | | 2022 | | | 2021 | | ||||||
Audit Fees(1) | | | | $ | 90,750 | | | | | $ | 85,500 | | |
Audit-Related Fees(2) | | | | $ | 60,000 | | | | | $ | 40,000 | | |
Tax Fees(3) | | | | $ | 12,000 | | | | | $ | 12,000 | | |
Total Fees | | | | $ | 162,750 | | | | | $ | 137,500 | | |
| /s/ Uri Yablonka Uri Yablonka, Chief Business Officer and Secretary New York, New York November 8, 2023 | | | | |